Proteomic Assessment of Extracellular Vesicles from Canine Tissue Explants as a Pipeline to Identify Molecular Targets in Osteosarcoma: PSMD14/Rpn11 as a Proof of Principle
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Luu, Anita K | - |
dc.contributor.author | Cadieux, Mia | - |
dc.contributor.author | Wong, Mackenzie | - |
dc.contributor.author | Macdonald, Rachel | - |
dc.contributor.author | Jones, Robert | - |
dc.contributor.author | Choi, Dongsic | - |
dc.contributor.author | Oblak, Michelle | - |
dc.contributor.author | Brisson, Brigitte | - |
dc.contributor.author | Sauer, Scott | - |
dc.contributor.author | Chafitz, James | - |
dc.contributor.author | Warshawsky, David | - |
dc.contributor.author | Wood, Geoffrey A | - |
dc.contributor.author | Viloria-Petit, Alicia M | - |
dc.date.accessioned | 2022-04-07T01:40:07Z | - |
dc.date.available | 2022-04-07T01:40:07Z | - |
dc.date.issued | 2022-03 | - |
dc.identifier.issn | 1661-6596 | - |
dc.identifier.issn | 1422-0067 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/20574 | - |
dc.description.abstract | Osteosarcoma (OS) is a highly malignant bone tumour that has seen little improvement in treatment modalities in the past 30 years. Understanding what molecules contribute to OS biology could aid in the discovery of novel therapies. Extracellular vesicles (EVs) serve as a mode of cell-to-cell communication and have the potential to uncover novel protein signatures. In our research, we developed a novel pipeline to isolate, characterize, and profile EVs from normal bone and osteosarcoma tissue explants from canine OS patients. Proteomic analysis of vesicle preparations revealed a protein signature related to protein metabolism. One molecule of interest, PSMD14/Rpn11, was explored further given its prognostic potential in human and canine OS, and its targetability with the drug capzimin. In vitro experiments demonstrated that capzimin induces apoptosis and reduces clonogenic survival, proliferation, and migration in two metastatic canine OS cell lines. Capzimin also reduces the viability of metastatic human OS cells cultured under 3D conditions that mimic the growth of OS cells at secondary sites. This unique pipeline can improve our understanding of OS biology and identify new prognostic markers and molecular targets for both canine and human OS patients. | - |
dc.format.extent | 25 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | - |
dc.title | Proteomic Assessment of Extracellular Vesicles from Canine Tissue Explants as a Pipeline to Identify Molecular Targets in Osteosarcoma: PSMD14/Rpn11 as a Proof of Principle | - |
dc.type | Article | - |
dc.publisher.location | 스위스 | - |
dc.identifier.doi | 10.3390/ijms23063256 | - |
dc.identifier.scopusid | 2-s2.0-85126677303 | - |
dc.identifier.wosid | 000775326300001 | - |
dc.identifier.bibliographicCitation | International Journal of Molecular Sciences, v.23, no.6, pp 1 - 25 | - |
dc.citation.title | International Journal of Molecular Sciences | - |
dc.citation.volume | 23 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 25 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | DNA TOPOISOMERASE-II | - |
dc.subject.keywordPlus | APPENDICULAR OSTEOSARCOMA | - |
dc.subject.keywordPlus | PROTEASOME INHIBITOR | - |
dc.subject.keywordPlus | SOLID TUMORS | - |
dc.subject.keywordPlus | KAPPA-B | - |
dc.subject.keywordPlus | AMPUTATION | - |
dc.subject.keywordPlus | DOGS | - |
dc.subject.keywordPlus | DOXORUBICIN | - |
dc.subject.keywordPlus | BORTEZOMIB | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordAuthor | osteosarcoma | - |
dc.subject.keywordAuthor | extracellular vesicles | - |
dc.subject.keywordAuthor | tissue explants | - |
dc.subject.keywordAuthor | biomarker discovery | - |
dc.subject.keywordAuthor | molecular targets | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.